// App-Quantinova.ai

: Serum Cystatin C Is a Significant Marker of Early Glomerular and Tubular Interstitial Lesions in Patients with Primary Glomerulonephritis: Results from Single Center Cross-Sectional Single-Blind Study

Researchers

Presenter

  • ElenaSaganova

Principal Investigators

  • OlgaGalkina

  • VasiliySipovskii

  • AlexeySmirnov

Medical Centers

  • Pavlov First Saint Petersburg State Medical University, Saint‐Petersburg, Russian Federation

Locations

  • Russia

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Cystatin C

Drug/Treatment

  • Prednisolone

Outcome

  • N/A

Study Design

  • Double Blind/Blinded

  • Cross-Sectional

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved